Silencing and Un-silencing of Tetracycline-Controlled Genes in Neurons

• Peixin Zhu,

  Affiliation Max Planck Institute for Medical Research, Heidelberg, Germany

  ⨯
• M. Isabel Aller,

  Affiliation Department of Clinical Neurobiology, University of Heidelberg, Heidelberg, Germany

  ⨯
• Udo Baron,

  Affiliation Epiontis GmbH, Berlin, Germany

  ⨯
• Sidney Cambridge,

  Affiliation Max Planck Institute of Neurobiology, Munich-Martinsried, Germany

  ⨯
• Melanie Bausen,

  Affiliation Max Planck Institute for Medical Research, Heidelberg, Germany

  ⨯
• Jan Herb,

  Affiliation Max Planck Institute for Medical Research, Heidelberg, Germany

  ⨯
• Jürgen Sawinski,

  Affiliation Max Planck Institute for Medical Research, Heidelberg, Germany

  ⨯
• Ali Cetin,

  Affiliation Max Planck Institute for Medical Research, Heidelberg, Germany

  ⨯
• Pavel Osten,

  Affiliation Max Planck Institute for Medical Research, Heidelberg, Germany

  ⨯
• Mark L. Nelson,

  Affiliation Paratek Pharmaceuticals Inc., Boston, Massachusetts, United States of America

  ⨯
• Sebastian Kügler,

  Affiliation Department of Neurology, University of Göttingen Medical School, Göttingen, Germany

  ⨯
• Peter H. Seeburg,

  Affiliation Max Planck Institute for Medical Research, Heidelberg, Germany

  ⨯
• Rolf Sprengel,

  Affiliation Max Planck Institute for Medical Research, Heidelberg, Germany

  ⨯
• Mazahir T. Hasan

  *To whom correspondence should be addressed. E-mail: mhasan@mpimf-heidelberg.mpg.de

  Affiliations Max Planck Institute for Medical Research, Heidelberg, Germany, Max Planck Institute of Neurobiology, Munich-Martinsried, Germany

  ⨯